Loading...

ICS Global Limited

ICS.AX•ASX
Financial Services
Shell Companies
A$2.19
A$0.00(0.00%)

ICS Global Limited (ICS.AX) Stock Overview

Explore ICS Global Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap23.2M
P/E Ratio-65.76
EPS (TTM)$-0.14
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$2.26

ICS.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ICS Global Limited (ICS.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $2.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -65.76 and a market capitalization of 23.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for ICS.AXStats details for ICS.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for ICS.AXAnalyst Recommendations details for ICS.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

ICS Global Limited does not have significant operations. Previously, it was engaged in the provision of medical billing services primarily in the United Kingdom. The company was incorporated in 1996 and is based in Sydney, Australia.

CEO

Richard Barry

Employees

19

Headquarters

20 Bond Street, Sydney, NSW

Founded

1999

Frequently Asked Questions

;